My Profile
Rolfe Winkler
Your guide to
the capital jungle
See all posts
Sat 28 Nov 2009 | 2:55 EST
You are here:
Home
>
Business & Finance
>
Stocks
> Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSS
Widgets
Mobile
Podcasts
Newsletters
Your View
Make Reuters My Homepage
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters
Officers and Directors For Verenium Corporation
Verenium Corporation (VRNM.O) (Consolidated Issue listed on NASDAQ Global Market)
sector:
Healthcare
.
industry:
Biotechnology
ยท
View
VRNM
on other exchanges
As of 27 Nov 2009
4.37
USD
Price Change
+0.03
Percent Change
+0.69%
Analyst Recommendations
Research Another Stock:
Symbol Look-up
Independent Research
|
Broker Research
Summary
Biographies
Basic Compensation
Options Compensation
Name
Age
Since
Current Position
Black, Jeffrey
40
2009
Senior Vice President, Chief Accounting Officer
Riva, Carlos
55
2007
President, Chief Executive Officer, Director
Haines, Gerald
46
2008
Executive Vice President, Chief Legal Officer, Secretary
Baum, William
64
2002
Executive Vice President - Business Development
Johnson, Peter
61
1999
Director
Wenzinger, Cheryl
60
2004
Director
Kaufmann, Fernand
66
2004
Director
Zak, Michael
55
2007
Director
Ruch, Joshua
59
2007
Director
Rich, Simon
64
2008
Director
Dee, John
51
2008
Director
Levine, James
38
2009
Chief Financial Officer, Executive Vice President
Cavanaugh, James
72
1998
Chairman of the Board
Find out more about VRNM.O
Insider Trading